Ketamine
PharmaTher and Vitruvias sign collaboration agreement to commercialise ketamine-based treatment in the US
June 21, 2023Medical Communications Ketamine, Neurology, PharmaTher, Vitruvias, commercialisation
Specialty pharmaceutical companies, Canadian PharmaTher and US-based Vitruvias, have entered into a commercialisation partnership to bring Ketarx products to the …
Top Ten most popular articles on Pharmafile.com this week
January 31, 2020Medical Communications Janseen, Ketamine, NHS, NICE, Nasal sprays, Nasl, Top 10 of the week, top 10
This week nasal sprays based on illegal recreational drugs feature prominently, as the FDA has moved to approve Lannett Company’s …
Ketamine’s antidepressant effects may be linked to brain’s opioid system
September 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ketamine, antidepressant, depression, mental health, opioid
Ketamine’s antidepressant effect works through the activation of the brains opioid receptors, a new study published in The American Journal …
US hospital’s ketamine study forced to a halt over consent concerns
June 27, 2018Research and Development Hennepin Healthcare, Ketamine, pharma
Minneapolis-based hospital Hennepin County Medical Center has put the brakes on a clinical trial investigating the efficacy of ketamine in …
J&J’s ketamine-based antidepressant showed mixed success at Phase 3
May 8, 2018Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, Ketamine, antidepressant, depression, esketamine, pharma
Johnson & Johnson has revealed new data on its new depression drug esketamine, its chemically ‘left-handed’ version of the controlled …
J&J’s ketamine nasal spray for depression continues to impress
April 16, 2018Research and Development, Sales and Marketing Johnson & Johnson, Ketamine, biotech, drugs, pharma, pharmaceutical
New treatments for depression are few and far between; pharmaceutical companies have shied away from trying to develop new therapeutics …
First large-scale study gives hope for ketamine as a depression therapy
May 3, 2017Research and Development Ketamine, depression, mental health
While the development of truly innovative mental health therapies has ground to a halt somewhat, scientific research in the field …
Ketamine found to offer hope as last-resort treatment for depression
April 6, 2017Research and Development Ketamine, University of Oxford
Researchers from the University of Oxford have conducted a six-year study looking into the potential therapeutic effects of ketamine as …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
